All News

Although intensive glycemic control has been the standard of care for delaying the onset and slowing the progression of microvascular disease, treatment burden and unwanted effects like weight gain, hypoglycemia, and gastrointestinal side effects do affect patients’ quality of life. Patient preferences and their views of treatment burden need to be considered when making decisions about glycemic treatment, according to a report published online for JAMA Internal Medicine.

Now that the National Association of Boards of Pharmacy (NABP) has secured the Internet domain .pharmacy, the group hopes the designation will help consumers identify legitimate online pharmacies and related resources.

Retail pharmacies that use Cardinal Health’s Heart Health Specialized Care Center will now have more tools to help patients manage cardiovascular health and prevent heart disease.

More than 80% of healthcare employees dilute certain IV push medications, which is not always necessary, according to a new survey conducted by the Institute for Safe Medication Practices (ISMP).

Kim Ankenbruck has a knack for expressing what many of her fellow pharmacists are thinking. Here, she tackles the question of how to practice integrity in an environment designed to punish the attempt.

On July 1, 2014, FDA’s Center for Drug Evaluation and Research Small Business and Industry Assistance (CDER SBIA) will host a webinar designed to help manufacturers, repackagers, wholesale distributors, and dispensers identify suspect products.

FDA’s review of the hypertension drug olmesartan found no clear evidence of increased heart risks for diabetes patients, but the agency will require additional information be provided on the drug’s labels.

Last November, the American Heart Association (AHA) and the American College of Cardiology (ACC) recommended statin therapy for approximately 33 million more Americans who don’t have cardiovascular disease (CVD), but have an estimated 10-year CV risk of 7.5% or higher.

If it’s a positive return on investment you seek, look no further than your local free medical clinic.

The California State Supreme Court recently upheld a ruling that allows healthcare plans serving the poor to ignore what it costs pharmacies to obtain drugs when establishing Medi-Cal reimbursement rates.

A new law that will allow pharmacists in Kansas to create collaborative agreements with physicians will take effect in July.

A Utah pharmacist recently pled no contest to charges he filled a fraudulent prescription with M&Ms instead of pain pills, according to a report in the Salt Lake Tribune.

The Institute for Safe Medication Practices (ISMP) recently warned about alphanumeric symbol mixups, particularly in handwritten scripts, which have led to medical errors.

The Boerhringer Ingleheim-Eli Lilly Diabetes Alliance presented more than 40 posters, abstracts, and oral presentations June 13-17 at the 74th American Diabetes Association Scientific Sessions in San Francisco.

Pharmacy groups, patient advocates, and many businesses are urging Congress to pass legislation that would allow Medicare beneficiaries to use discounted or preferred copays at independent pharmacies willing to accept the terms of Part D prescription drug plans.

A federal appeals court has ruled in Walgreens’ favor regarding a pharmacist who was dismissed after shooting at armed robbers with a legally concealed handgun.

Ohio Gov. John Kasich has signed an emergency order allowing pharmacists to administer the measles, mumps, and rubella vaccine to people 18 years or older.

Penn State Hershey Health System has joined the Rite Aid Health Alliance, which provides support to individuals with chronic and poly-chronic health conditions.

Electronic prescribing was supposed to be the savior of pharmacy. Things haven’t quite worked out that way.

Costly treatments are expected to drive unprecedented growth in U.S. drug spending over the next two years. Some analysts say that’s not good news for consumers or most pharmacists.

Patients must be taught what their meds mean and why they're taking them. That's a job for the pharmacist.

A direct response to the devastating fungal meningitis outbreak linked to NECC, the Drug Quality and Security Act gives FDA needed regulatory power to oversee compounders.

Pharmacies that want to keep their 340B Medicaid contracts had better police themselves for compliance irregularities and prepare for increased audits and oversight.

Approximately 7.8% of adults and 10% of children in the U.S. are afflicted with hay fever symptoms. Pharmacists are able to offer a number of over-the-counter solutions to improve patients' quality of life.

In May, the Centers for Medicare & Medicaid Services (CMS) issued its final rule for 2015 Part D prescription drug benefit programs, requiring increased price transparency for pharmacies by 2016.

In a study of patients at high risk for stroke, patients without periprocedural warfarin who were bridged with low-molecular weight heparin showed a >10-fold increased odds of ischemic stroke or transient ischemic attack (TIA) in the 48 hours after ablation for atrial fibrillation, compared with those on uninterrupted warfarin.

FDA approved eslicarbazepine acetate on November 8, 2013 as an adjunctive treatment of partial-onset seizures in adults.